Corneal endothelial repair: Regulation of prostaglandin E2 synthesis

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 7, 1996, Pages 1294-1301

  Jumblatt, Marcia M ^a   Willer, Sharon S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

corneal endothelial cells; cytokines; prostaglandins; wound healing

Indexed keywords

PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA INJURY; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RABBIT; TISSUE REPAIR; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; CELLS, CULTURED; CYTOKINES; DINOPROSTONE; ENDOTHELIUM, CORNEAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GROWTH SUBSTANCES; OXYTOCICS; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; RABBITS; STEROIDS; WOUND HEALING;

EID: 0029973473     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Yee RW, Geroski DH, Masuda M, Champeau EJ, Meyer LA, Edelhauser HF. Correlation of endothelial pump-site density, barrier function and morphology in wound repair. Invest Ophthalmol Vis Sci. 1985;26:1191-1202.
2. Matsuda M, Asawa M, Edelhauser HF, Bartels SP, Neufeld AH, Kenyon KR. Cellular migration and morphology in corneal endothelial wound repair. Invest Ophthalmol Vis Sci. 1985;26:443-449.
3. 2. Invest Ophthalmol Vis Sci. 1994;35:2783-2790.
4. Joyce NC, Matkin ED, Neufeld AH. Corneal endothelial wound closure in vitro: Effects of EGF and indomethacin. Invest Ophthalmol Vis Sci. 1989;30:1548-1559.
5. 2: A mediator of corneal endothelial wound repair in vitro. Am J Physiol. 1994; 266:C269-C275.
6. Kay E, Gu X, Smith R. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer. Invest Ophthalmol Vis Sci. 1994;35:2427-2435.
7. Wilson S, Schultz G, Chegini N, Weng J, He Y. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor and interleukin 1 proteins in the eye. Exp Eye Res. 1994; 59:63-71.
8. Wilson SE, Lloyd SA. Epidermal growth factor and its receptor, basic fibroblast growth factor, transforming growth factor beta-1 and interleukin-1 alpha messenger RNA production in human corneal endothelial cells. Invest Ophthalmol Vis Sci. 1991;32:2747-2756.
9. 2 subtype. Invest Ophthalmol Vis Sci. 1991;32:360-365.
10. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J. 1989;259:315-324.
11. Bazan HEP. Corneal injury alters eicosanoid formation in the rabbit anterior segment in vivo. Invest Ophthalmol Vis Sci. 1985;26:474-480.
12. Lowry OH, Rosenbrough NJ, Famm AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
13. Xie W, Robertson DL, Simmons DL. Mitogen-inducible Prostaglandin G/H synthase: A new target for nonsteroidal anti-inflammatory drugs. Drug Dev Res. 1992;25:249-265.
14. Lin N, Bazan H. Protein kinase C subspecies in rabbit corneal epithelium: increased activity of alpha subspecies during wound healing. Curr Eye Res. 1992;11:899-907.
15. 2: Effects on corneal endothelial migration and monolayer spreading during wound repair in vitro. Curr Eye Res. 1995;14:601-609.
16. Joyce N, Meklir B. Protein kinase C activation during corneal endothelial wound repair. Invest Ophthalmol Vis Sci. 1992;33:1958-1973.
17. Masferrer J, Reddy S, Zweifel B, et al. In vivo glucocorticoids regulated cyclooxygenase 2 but not cyclooxygenase 1 in peritoneal macrophages. J Pharmacol Exp Ther. 1994;270:1340-1344.
18. 2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA. 1992;89:6147-6151.
19. Tordjman C, Coge F, Andre N, Rique H, Spedding M, Bonnet J. Characterization of cyclooxygenase 1 and 2 expression in mouse resident peritoneal macrophages in vitro: Interactions of non steroidal anti-inflammatory drugs with COX 2. Biochim Biophys Acta. 1995;1256:249-256.